<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40894374</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2474-8714</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Structural heart : the journal of the Heart Team</Title><ISOAbbreviation>Struct Heart</ISOAbbreviation></Journal><ArticleTitle>Patent Foramen Ovale Closure in Older Patients With Cryptogenic Stroke: Current Evidence and Next Steps.</ArticleTitle><Pagination><StartPage>100699</StartPage><MedlinePgn>100699</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100699</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.shj.2025.100699</ELocationID><Abstract><AbstractText>Stroke is a major cause of morbidity and mortality worldwide, with recurrence risk increasing with age. In patients over 60 years of age with cryptogenic stroke, paradoxical embolism through a patent foramen ovale may be an important pathophysiology contributor, particularly when high-risk anatomical features (e.g., large shunt, atrial septal aneurysm) are present. Although patent foramen ovale closure has become a standard therapy in younger cryptogenic stroke patients, its benefit in older adults remains uncertain due to limited evidence and the need to exclude highly prevalent alternative causes like atrial fibrillation or carotid disease. A multidisciplinary heart-brain team is critical for accurate diagnosis, patient selection, and shared decision-making. Current guidelines vary and highlight the need for more robust data in this population. Recent observational studies suggest that patent foramen ovale closure in older patients may be safe and potentially reduce stroke recurrence compared to antithrombotic therapy alone. Ongoing randomized controlled trials are expected to provide definitive evidence on the efficacy and safety of patent foramen ovale closure in this age group, guiding future clinical decisions.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vidal-Cal&#xe9;s</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llull</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Hospital Cl&#xed;nic, University of Barcelona, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanthier</LastName><ForeName>Sylvain</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurovascular Program and Research Center, H&#xf4;pital du Sacr&#xe9;-Coeur-de-Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Portillo</LastName><ForeName>Juan H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desjardins</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, Centre Hospitalier Universitaire de Qu&#xe9;bec, Qu&#xe9;bec City, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houde</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, Centre Hospitalier Universitaire de Qu&#xe9;bec, Qu&#xe9;bec City, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sirois</LastName><ForeName>Pierre-Olivier</ForeName><Initials>PO</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freixa</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Institut Cl&#xed;nic Cardiovascular, Hospital Cl&#xed;nic, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chamorro</LastName><ForeName>&#xc1;ngel</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Hospital Cl&#xed;nic, University of Barcelona, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rod&#xe9;s-Cabau</LastName><ForeName>Josep</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, Centre Hospitalier Universitaire de Qu&#xe9;bec, Qu&#xe9;bec City, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Research and Innovation, Cl&#xed;nic Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Struct Heart</MedlineTA><NlmUniqueID>101743256</NlmUniqueID><ISSNLinking>2474-8706</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cryptogenic stroke</Keyword><Keyword MajorTopicYN="N">Elderly patients</Keyword><Keyword MajorTopicYN="N">PFO occluder</Keyword><Keyword MajorTopicYN="N">Patent foramen ovale</Keyword><Keyword MajorTopicYN="N">Stroke prevention</Keyword></KeywordList><CoiStatement>J Rod&#xe9;s-Cabau has received institutional research grants and consultant/speaker fees from Edwards Lifesciences, Medtronic, and Abbott. The rest of the authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>22</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>22</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>16</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40894374</ArticleId><ArticleId IdType="pmc">PMC12399247</ArticleId><ArticleId IdType="doi">10.1016/j.shj.2025.100699</ArticleId><ArticleId IdType="pii">S2474-8706(25)00291-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>S&#xf8;ndergaard L., Kasner S.E., Rhodes J.F., et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377(11):1033&#x2013;1042. doi: 10.1056/NEJMoa1707404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1707404</ArticleId><ArticleId IdType="pubmed">28902580</ArticleId></ArticleIdList></Reference><Reference><Citation>Saver J.L., Carroll J.D., Thaler D.E., et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377(11):1022&#x2013;1032. doi: 10.1056/NEJMoa1610057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1610057</ArticleId><ArticleId IdType="pubmed">28902590</ArticleId></ArticleIdList></Reference><Reference><Citation>Mas J.L., Derumeaux G., Guillon B., et al. Patent foramen ovale closure or anticoagulation vs. Antiplatelets after stroke. N Engl J Med. 2017;377(11):1011&#x2013;1021. doi: 10.1056/NEJMoa1705915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1705915</ArticleId><ArticleId IdType="pubmed">28902593</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee P.H., Song J.K., Kim J.S., et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial. J Am Coll Cardiol. 2018;71(20):2335&#x2013;2342. doi: 10.1016/j.jacc.2018.02.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.02.046</ArticleId><ArticleId IdType="pubmed">29544871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasner S.E., Rhodes J.F., Andersen G., et al. Five-year outcomes of PFO closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2021;384(10):970&#x2013;971. doi: 10.1056/NEJMc2033779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033779</ArticleId><ArticleId IdType="pubmed">33704944</ArticleId></ArticleIdList></Reference><Reference><Citation>Mess&#xe9; S.R., Gronseth G.S., Kent D.M., et al. Practice advisory update summary: patent foramen ovale and secondary stroke prevention: report of the guideline Subcommittee of the American Academy of Neurology. Neurology. 2020;94(20):876&#x2013;885. doi: 10.1212/wnl.0000000000009443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000009443</ArticleId><ArticleId IdType="pmc">PMC7526671</ArticleId><ArticleId IdType="pubmed">32350058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleindorfer D.O., Towfighi A., Chaturvedi S., et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364&#x2013;e467. doi: 10.1161/str.0000000000000375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/str.0000000000000375</ArticleId><ArticleId IdType="pubmed">34024117</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavinsky C.J., Szerlip M., Goldsweig A.M., et al. SCAI guidelines for the management of patent foramen ovale. J Soc Cardiovasc Angiogr Interv. 2022;1(4) doi: 10.1016/j.jscai.2022.100039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jscai.2022.100039</ArticleId><ArticleId IdType="pmc">PMC11307505</ArticleId><ArticleId IdType="pubmed">39131947</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladstone D.J., Lindsay M.P., Douketis J., et al. Canadian stroke best practice recommendations: secondary prevention of stroke update 2020. Can J Neurol Sci. 2022;49(3):315&#x2013;337. doi: 10.1017/cjn.2021.127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2021.127</ArticleId><ArticleId IdType="pubmed">34140063</ArticleId></ArticleIdList></Reference><Reference><Citation>Caso V., Turc G., Abdul-Rahim A.H., et al. European Stroke Organisation (ESO) guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke. Eur Stroke J. 2024;9(4):800&#x2013;834. doi: 10.1177/23969873241247978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23969873241247978</ArticleId><ArticleId IdType="pmc">PMC11569559</ArticleId><ArticleId IdType="pubmed">38752755</ArticleId></ArticleIdList></Reference><Reference><Citation>Handke M., Harloff A., Olschewski M., Hetzel A., Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007;357(22):2262&#x2013;2268. doi: 10.1056/NEJMoa071422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa071422</ArticleId><ArticleId IdType="pubmed">18046029</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzucco S., Li L., Binney L., Rothwell P.M. Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis. Lancet Neurol. 2018;17(7):609&#x2013;617. doi: 10.1016/s1474-4422(18)30167-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(18)30167-4</ArticleId><ArticleId IdType="pmc">PMC6004554</ArticleId><ArticleId IdType="pubmed">29887162</ArticleId></ArticleIdList></Reference><Reference><Citation>Farjat-Pasos J.I., Chamorro A., Lanthier S., et al. Cerebrovascular events in older patients with patent foramen ovale: current status and future perspectives. J Stroke. 2023;25(3):338&#x2013;349. doi: 10.5853/jos.2023.01599.</Citation><ArticleIdList><ArticleId IdType="doi">10.5853/jos.2023.01599</ArticleId><ArticleId IdType="pmc">PMC10574307</ArticleId><ArticleId IdType="pubmed">37813671</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee P.H., Kim J.S., Song J.K., et al. Device closure or antithrombotic therapy after cryptogenic stroke in elderly patients with a high-risk patent foramen ovale. J Stroke. 2024;26(2):242&#x2013;251. doi: 10.5853/jos.2023.03265.</Citation><ArticleIdList><ArticleId IdType="doi">10.5853/jos.2023.03265</ArticleId><ArticleId IdType="pmc">PMC11164578</ArticleId><ArticleId IdType="pubmed">38836271</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2021 Nervous System Disorders Collaborators Global, regional, and National burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(4):344&#x2013;381. doi: 10.1016/s1474-4422(24)00038-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(24)00038-3</ArticleId><ArticleId IdType="pmc">PMC10949203</ArticleId><ArticleId IdType="pubmed">38493795</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao C.W., Aday A.W., Almarzooq Z.I., et al. Heart disease and stroke statistics-2023 update: a report from the American heart association. Circulation. 2023;147(8):e93&#x2013;e621. doi: 10.1161/cir.0000000000001123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/cir.0000000000001123</ArticleId><ArticleId IdType="pmc">PMC12135016</ArticleId><ArticleId IdType="pubmed">36695182</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Wu J., Liu J., et al. Trends in the incidence of recurrent stroke at 5 years after the first-ever stroke in rural China: a population-based stroke surveillance from 1992 to 2017. Aging (Albany NY) 2019;11(6):1686&#x2013;1694. doi: 10.18632/aging.101862.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101862</ArticleId><ArticleId IdType="pmc">PMC6461163</ArticleId><ArticleId IdType="pubmed">30888967</ArticleId></ArticleIdList></Reference><Reference><Citation>Pristipino C., Sievert H., D'Ascenzo F., et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J. 2019;40(38):3182&#x2013;3195. doi: 10.1093/eurheartj/ehy649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy649</ArticleId><ArticleId IdType="pubmed">30358849</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C., Li H., Wang C., et al. Frequency and size of in situ thrombus within patent foramen ovale. Stroke. 2023;54(5):1205&#x2013;1213. doi: 10.1161/strokeaha.122.041524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.122.041524</ArticleId><ArticleId IdType="pubmed">36891906</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah P., Jimenez-Ruiz A., Gibson A., et al. Association between acute myocardial infarction and death in 386 patients with a thrombus straddling a patent foramen ovale. Int J Cardiol. 2021;342:1&#x2013;6. doi: 10.1016/j.ijcard.2021.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2021.07.007</ArticleId><ArticleId IdType="pubmed">34245792</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S., Bajaj N.S., Kumbhani D.J., Tuzcu E.M., Kapadia S.R. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism. JACC Cardiovasc Interv. 2012;5(7):777&#x2013;789. doi: 10.1016/j.jcin.2012.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2012.02.021</ArticleId><ArticleId IdType="pubmed">22814784</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein P.D., Hull R.D., Kayali F., Ghali W.A., Alshab A.K., Olson R.E. Venous thromboembolism according to age: the impact of an aging population. Arch Intern Med. 2004;164(20):2260&#x2013;2265. doi: 10.1001/archinte.164.20.2260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.164.20.2260</ArticleId><ArticleId IdType="pubmed">15534164</ArticleId></ArticleIdList></Reference><Reference><Citation>Henein M., Waldenstr&#xf6;m A., M&#xf6;rner S., Lindqvist P. The normal impact of age and gender on right heart structure and function. Echocardiography. 2014;31(1):5&#x2013;11. doi: 10.1111/echo.12289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/echo.12289</ArticleId><ArticleId IdType="pubmed">23822635</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaler D.E., Ruthazer R., Weimar C., et al. Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs. Neurology. 2014;83(3):221&#x2013;226. doi: 10.1212/wnl.0000000000000589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000000589</ArticleId><ArticleId IdType="pmc">PMC4117365</ArticleId><ArticleId IdType="pubmed">24928123</ArticleId></ArticleIdList></Reference><Reference><Citation>Turc G., Lee J.Y., Brochet E., Kim J.S., Song J.K., Mas J.L. Atrial septal aneurysm, shunt size, and recurrent stroke risk in patients with patent foramen ovale. J Am Coll Cardiol. 2020;75(18):2312&#x2013;2320. doi: 10.1016/j.jacc.2020.02.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.02.068</ArticleId><ArticleId IdType="pubmed">32381162</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.Y., Song J.K., Song J.M., et al. Association between anatomic features of atrial septal abnormalities obtained by omni-plane transesophageal echocardiography and stroke recurrence in cryptogenic stroke patients with patent foramen ovale. Am J Cardiol. 2010;106(1):129&#x2013;134. doi: 10.1016/j.amjcard.2010.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2010.02.025</ArticleId><ArticleId IdType="pubmed">20609660</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizzari G., Pizzino F., Zwicke D., et al. Patent foramen ovale: anatomical complexity and long-tunnel morphology related issues. Am J Cardiovasc Dis. 2021;11(3):316&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8303044</ArticleId><ArticleId IdType="pubmed">34322302</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q., Ahmad M. Eustachian valve, interatrial shunt, and paradoxical embolism. Echocardiography. 2020;37(6):939&#x2013;944. doi: 10.1111/echo.14682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/echo.14682</ArticleId><ArticleId IdType="pubmed">32426851</ArticleId></ArticleIdList></Reference><Reference><Citation>Wintzer-Wehekind J., Alperi A., Houde C., et al. Transcatheter closure of patent foramen ovale in patients older than 60 years of age with cryptogenic embolism. Rev Esp Cardiol (Engl Ed) 2020;73(3):219&#x2013;224. doi: 10.1016/j.rec.2019.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2019.07.003</ArticleId><ArticleId IdType="pubmed">31585849</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechat P., Mas J.L., Lascault G., et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318(18):1148&#x2013;1152. doi: 10.1056/nejm198805053181802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm198805053181802</ArticleId><ArticleId IdType="pubmed">3362165</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzucco S., Li L., Rothwell P.M. Prognosis of cryptogenic stroke with patent foramen ovale at older ages and implications for trials: a population-based study and systematic review. JAMA Neurol. 2020;77(10):1279&#x2013;1287. doi: 10.1001/jamaneurol.2020.1948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1948</ArticleId><ArticleId IdType="pmc">PMC7550974</ArticleId><ArticleId IdType="pubmed">32628255</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsheikh-Ali A.A., Thaler D.E., Kent D.M. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009;40(7):2349&#x2013;2355. doi: 10.1161/strokeaha.109.547828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.109.547828</ArticleId><ArticleId IdType="pmc">PMC2764355</ArticleId><ArticleId IdType="pubmed">19443800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent D.M., Ruthazer R., Weimar C., et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013;81(7):619&#x2013;625. doi: 10.1212/WNL.0b013e3182a08d59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a08d59</ArticleId><ArticleId IdType="pmc">PMC3775694</ArticleId><ArticleId IdType="pubmed">23864310</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent D.M., Saver J.L., Ruthazer R., et al. Risk of paradoxical embolism (RoPE)-Estimated attributable fraction correlates with the benefit of patent foramen ovale closure: an analysis of 3 trials. Stroke. 2020;51(10):3119&#x2013;3123. doi: 10.1161/strokeaha.120.029350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.120.029350</ArticleId><ArticleId IdType="pmc">PMC7831886</ArticleId><ArticleId IdType="pubmed">32921262</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent D.M., Saver J.L., Kasner S.E., et al. Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke. JAMA. 2021;326(22):2277&#x2013;2286. doi: 10.1001/jama.2021.20956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.20956</ArticleId><ArticleId IdType="pmc">PMC8672231</ArticleId><ArticleId IdType="pubmed">34905030</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgendy A.Y., Saver J.L., Amin Z., et al. Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke. JAMA Neurol. 2020;77(7):878&#x2013;886. doi: 10.1001/jamaneurol.2020.0458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.0458</ArticleId><ArticleId IdType="pubmed">32282016</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacoppo D., Caronna N., Frangieh A.H., et al. Long-term effectiveness and safety of transcatheter closure of patent foramen ovale compared with antithrombotic therapy alone: a meta-analysis of six randomised clinical trials and 3,560 patients with reconstructed time-to-event data. Eurointervention. 2018;14(8):857&#x2013;867. doi: 10.4244/eij-d-18-00341.</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/eij-d-18-00341</ArticleId><ArticleId IdType="pubmed">29901447</ArticleId></ArticleIdList></Reference><Reference><Citation>Mess&#xe9; S.R., Erus G., Bilello M., et al. Patent foramen ovale closure decreases the incidence but not the size of new brain infarction on magnetic resonance imaging: an analysis of the REDUCE trial. Stroke. 2021;52(11):3419&#x2013;3426. doi: 10.1161/strokeaha.121.034451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.121.034451</ArticleId><ArticleId IdType="pmc">PMC8545852</ArticleId><ArticleId IdType="pubmed">34455822</ArticleId></ArticleIdList></Reference><Reference><Citation>Alperi A., Guedeney P., Horlick E., et al. Transcatheter closure of patent foramen ovale in older patients with cryptogenic thromboembolic events. Circ Cardiovasc Interv. 2022;15(7) doi: 10.1161/circinterventions.121.011652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circinterventions.121.011652</ArticleId><ArticleId IdType="pubmed">35735021</ArticleId></ArticleIdList></Reference><Reference><Citation>Akagi T., Hara H., Kanazawa H., et al. Real-world patent foramen ovale (PFO) closure in Japan - 30-day clinical outcomes from the amplatzer(TM) PFO occluder Japan post-marketing surveillance study. Circ J. 2024;88(9):1391&#x2013;1397. doi: 10.1253/circj.CJ-24-0080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-24-0080</ArticleId><ArticleId IdType="pubmed">38735702</ArticleId></ArticleIdList></Reference><Reference><Citation>Farjat-Pasos J.I., Guedeney P., Horlick E., et al. Determinants of adverse outcomes following patent foramen ovale closure in elderly patients. EuroIntervention. 2024;20(16):1029&#x2013;1038. doi: 10.4244/eij-d-24-00156.</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/eij-d-24-00156</ArticleId><ArticleId IdType="pmc">PMC11317834</ArticleId><ArticleId IdType="pubmed">39155753</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon H., Lee P.H., Song J.K., Kwon S.U., Kang D.W., Kim J.S. Patent foramen ovale closure in old stroke patients: a subgroup analysis of the DEFENSE-PFO trial. J Stroke. 2021;23(2):289&#x2013;292. doi: 10.5853/jos.2021.00647.</Citation><ArticleIdList><ArticleId IdType="doi">10.5853/jos.2021.00647</ArticleId><ArticleId IdType="pmc">PMC8189858</ArticleId><ArticleId IdType="pubmed">34102766</ArticleId></ArticleIdList></Reference><Reference><Citation>Poli S., Siebert E., Mbroh J., et al. Closure or medical therapy of patent foramen ovale in cryptogenic stroke: prospective case series. Neurol Res Pract. 2021;3(1):16. doi: 10.1186/s42466-021-00114-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-021-00114-3</ArticleId><ArticleId IdType="pmc">PMC8015114</ArticleId><ArticleId IdType="pubmed">33789756</ArticleId></ArticleIdList></Reference><Reference><Citation>Satpathy R., Rodes-Cabau J., Thaler D., et al. TCT-113 patent foramen ovale closure in patients &gt;60 Years: age stratified results from U.S. Medicare beneficiaries. JACC. 2024;84(18_Supplement):B281&#x2013;B282. doi: 10.1016/j.jacc.2024.09.853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2024.09.853</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahl A., Tai T., Praz F., et al. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size. JACC Cardiovasc Interv. 2009;2(2):116&#x2013;123. doi: 10.1016/j.jcin.2008.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2008.09.013</ArticleId><ArticleId IdType="pubmed">19463412</ArticleId></ArticleIdList></Reference><Reference><Citation>Scacciatella P., Meynet I., Presbitero P., et al. Recurrent cerebral ischemia after patent foramen ovale percutaneous closure in older patients: a two-center registry study. Catheter Cardiovasc Interv. 2016;87(3):508&#x2013;514. doi: 10.1002/ccd.26053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.26053</ArticleId><ArticleId IdType="pubmed">26106024</ArticleId></ArticleIdList></Reference><Reference><Citation>Homma S., DiTullio M.R., Sacco R.L., Sciacca R.R., Mohr J.P. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale. Stroke. 2004;35(9):2145&#x2013;2149. doi: 10.1161/01.Str.0000135773.24116.18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.Str.0000135773.24116.18</ArticleId><ArticleId IdType="pubmed">15232117</ArticleId></ArticleIdList></Reference><Reference><Citation>Collado F.M.S., Kavinsky C.J. The heart-brain team approach in patent foramen ovale closure. Front Neurol. 2020;11 doi: 10.3389/fneur.2020.561938.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.561938</ArticleId><ArticleId IdType="pmc">PMC7593563</ArticleId><ArticleId IdType="pubmed">33178106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.S., Thijs V., Yudi M., et al. Establishment of the heart and brain team for patent foramen ovale closure in stroke patients: an expert opinion. J Stroke. 2022;24(3):345&#x2013;351. doi: 10.5853/jos.2022.02103.</Citation><ArticleIdList><ArticleId IdType="doi">10.5853/jos.2022.02103</ArticleId><ArticleId IdType="pmc">PMC9561221</ArticleId><ArticleId IdType="pubmed">36221937</ArticleId></ArticleIdList></Reference><Reference><Citation>Droste D.W., Schmidt-Rimpler C., Wichter T., et al. Right-to-left-shunts detected by transesophageal echocardiography and transcranial Doppler sonography. Cerebrovasc Dis. 2004;17(2-3):191&#x2013;196. doi: 10.1159/000075790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000075790</ArticleId><ArticleId IdType="pubmed">14707421</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G., Triantafyllou S., Palaiodimou L., et al. Prolonged cardiac monitoring and stroke recurrence: a meta-analysis. Neurology. 2022;98(19):e1942&#x2013;e1952. doi: 10.1212/wnl.0000000000200227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000200227</ArticleId><ArticleId IdType="pubmed">35264426</ArticleId></ArticleIdList></Reference><Reference><Citation>Buck B.H., Hill M.D., Quinn F.R., et al. Effect of implantable vs prolonged external electrocardiographic monitoring on atrial fibrillation detection in patients with ischemic stroke: the PER DIEM randomized clinical trial. JAMA. 2021;325(21):2160&#x2013;2168. doi: 10.1001/jama.2021.6128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.6128</ArticleId><ArticleId IdType="pmc">PMC8170545</ArticleId><ArticleId IdType="pubmed">34061146</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>